Last Updated: August 24, 2026

Litigation Details for WAG Acquisition, L.L.C. v. XM Satellite Radio, Inc. (S.D.N.Y. 2008)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in WAG Acquisition, L.L.C. v. XM Satellite Radio, Inc.
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Last updated: July 25, 2026

ecutive summary
WAG Acquisition, L.L.C. v. XM Satellite Radio, Inc. (E.D. New York, No. 1:08-cv-06357) is not a patent case in the provided prompt context, and no docket text, claims, asserted statutes, judgment or settlement terms are included. With no case-filings content, court orders, or final disposition data, a complete, accurate litigation summary and patent/IP analysis cannot be produced from the information provided.

WAG Acquisition v. XM Satellite Radio 1:08-cv-06357 litigation summary

No litigation summary can be generated from the case identifier alone. A litigation summary requires the pleaded causes of action, asserted rights, procedural posture, and disposition orders. None are supplied.

What claims did WAG Acquisition assert against XM Satellite Radio in 1:08-cv-06357?

A claims analysis requires the complaint (or amended complaint) text identifying:

  • the legal bases (e.g., patent infringement, copyright, contract, trademarks, antitrust)
  • the IP or commercial interests asserted
  • the time period and accused products/services

No complaint allegations are provided.

Was this an IP dispute, and what rights were at issue?

A determination of whether the dispute involved patent, copyright, or other IP rights requires docket filings or the complaint. No such record is provided.

What procedural history matters in WAG Acquisition v. XM Satellite Radio (E.D.N.Y. 2008)?

A procedural timeline requires dates and events such as:

  • complaint filing date and venue
  • motion to dismiss outcomes
  • claim construction, summary judgment, or trial activity
  • appellate steps (if any)
  • case closure disposition

None of these are included.

What did the court decide in WAG Acquisition v. XM Satellite Radio, and what was the outcome?

Case outcomes require the dispositive order or judgment entry. Without order text or a final judgment date and terms, an outcome summary cannot be stated.

Was there a settlement in WAG Acquisition v. XM Satellite Radio (No. 1:08-cv-06357)?

Settlement terms and confirmation require docket entries such as stipulations of dismissal, settlement agreements, or court approval orders. No settlement information is provided.

How does 1:08-cv-06357 compare with other XM Satellite Radio litigation?

A comparative analysis requires a defined comparator set (other cases, same patents, same parties, similar claims). No supporting litigation list is provided.

What patent estate or Orange Book issues exist for this dispute?

No patent numbers, drug products, FDA listings, or Orange Book identifiers are supplied. Without asserted patents or link to an FDA product, no patent estate analysis is possible.

What generic entry risks would be implicated by this litigation?

Generic entry risk depends on whether the case targets a specific branded product or alleges patent infringement tied to FDA approvals. No product or FDA pathway is stated.

Which companies are challenging XM Satellite Radio-related rights in litigation like 1:08-cv-06357?

This requires a docket-based universe of filings and parties. None is provided.

Key Takeaways

  • Case identifier alone is insufficient to produce an accurate litigation summary or IP/patent analysis.
  • No docket substance (complaint, orders, judgments, or settlement terms) is included, preventing a fact-based account.

FAQs

  1. What is the difference between docket identification and a litigation summary?
  2. How are patent cases usually summarized from a docket?
  3. What filings determine the asserted claims in federal court?
  4. What documents confirm settlement in US litigation?
  5. How do final judgments affect future licensing or enforcement strategy?

References

  1. U.S. District Court for the Eastern District of New York. WAG Acquisition, L.L.C. v. XM Satellite Radio, Inc., No. 1:08-cv-06357. (Case docket reference provided).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.